FibroBiologics, Inc. (FBLG)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.84
- As of
Kresmion compiles this page from FBLG's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
FibroBiologics, Inc. (FBLG): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-16.
See the full FBLG dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for FBLG on one page. Preview it with sample data, then open it live with a free account.
Preview the FBLG dossierActive events for FBLG
- mediumEarnings above estimates
Q2-2026: Beat consensus by 10.1%, EPS $-0.66 vs $-0.7344 estimate
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in FBLG
- mediumEarnings below estimates
Q3-2025: Missed consensus by 18.6% - EPS $-2.6 vs $-2.193 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 66.4% - EPS $-0.6 vs $-1.785 estimate
FREE, NO ACCOUNT
Every event on FBLG, as it fires
New filings, 13F moves and cross asset events on FBLG land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, FBLG
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
FBLG's 10-Q filed Nov 16, 2026 states:
These factors raise substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the condensed consolidated financial statements.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on FBLG
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in FBLG on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on FBLG in the last 180 days.
Upstream: SEC EDGAR filings for FBLG
Kresmion, "FibroBiologics, Inc. (FBLG) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/FBLG. Upstream data: SEC EDGAR filings for FBLG.
Link to this data (HTML):
<a href="https://kresmion.com/research/FBLG">FibroBiologics, Inc. (FBLG) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow FBLG on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to FBLG for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.